These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 17048303)

  • 1. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
    Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
    Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
    Khalilzadeh O; Mojazi Amiri H; Tahvildari M; Anvari M; Esteghamati A; Mobarra Z; Tehranchinia Z; Rashidi A; Amirzargar A
    Arch Dermatol Res; 2009 Oct; 301(10):719-23. PubMed ID: 19037649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
    Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
    Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region.
    Frydecka I; Daroszewski J; Suwalska K; Zołedziowska M; Tutak A; Słowik M; Potoczek S; Dobosz T
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):369-74. PubMed ID: 15507878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
    Nakkash-Chmaisse H; Makki RF; Abdelhamid E; Fakhoury H; Salti NN; Salti I
    Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.
    Han S; Zhang S; Zhang W; Li R; Li Y; Wang Z; Xie Y; Mao Y
    Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
    Kouki T; Gardine CA; Yanagawa T; Degroot LJ
    J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
    Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S
    Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
    Namo Cury A; Longui CA; Kochi C; Calliari LE; Scalissi N; Salles JE; Neves Rocha M; Barbosa de Melo M; Rezende Melo M; Monte O
    Horm Res; 2008; 70(1):36-41. PubMed ID: 18493148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction.
    Kimura H; Kato Y; Shimizu S; Takano K; Sato K
    Thyroid; 2009 Sep; 19(9):975-81. PubMed ID: 19731979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
    Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H
    Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy.
    Mukai T; Hiromatsu Y; Ichimura M; Fukutani T; Kaku H; Miyake I; Shoji S; Koda Y; Bednarczuk T
    Thyroid; 2006 Mar; 16(3):243-8. PubMed ID: 16571086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of CTLA-4 exon 1 A49-->G polymorphism with sCTLA-4 and Th1/Th2 bias in idiopathic dilated cardiomyopathy].
    Liu W; Li WM; Gao C; Wang XR; Li DM; Sun NL
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3221-4. PubMed ID: 16405845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 gene A-G polymorphism and childhood Graves' disease.
    Yung E; Cheng PS; Fok TF; Wong GW
    Clin Endocrinol (Oxf); 2002 May; 56(5):649-53. PubMed ID: 12030917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.